CVR: 12335040
DANIPHARM A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1988. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Peter Rørvig. The company is owned by H&P Rørvig Holding A/S. The company has 24 employees. In 2025, the company reported a gross profit of DKK 37,586,751 and a net result of DKK 13,717,304 compared with DKK 5,113,647 the year before. Equity amounted to DKK 60,280,949.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive handel, produktion og forskning
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | - | 13.7 mio. | 113 mio. | 60.3 mio. | 28 | |
| 2024 | - | 5.1 mio. | 95.6 mio. | 46.6 mio. | 26 | |
| 2023 | - | 5.4 mio. | 87.1 mio. | 41.4 mio. | 28 | |
| 2022 | - | 8.2 mio. | 78.3 mio. | 36.1 mio. | 26 | |
| 2021 | - | 2.9 mio. | 73.2 mio. | 29.9 mio. | 25 | |
| 2020 | 91.6 mio. | 5.8 mio. | 68.9 mio. | 26.9 mio. | 22 | |
| 2019 | - | 16.3 mio. | 34 mio. | 21.2 mio. | 21 | |
| 2018 | - | 10.2 mio. | 36.4 mio. | 24.8 mio. | 22 | |
| 2017 | 93.6 mio. | 11.3 mio. | 64.8 mio. | 50.6 mio. | 26 | |
| 2016 | 85.2 mio. | 15.2 mio. | 56 mio. | 41.8 mio. | 22 | |
| 2015 | 85.1 mio. | 11.3 mio. | 42.8 mio. | 26.5 mio. | 23 | |
| 2014 | 90.1 mio. | 8.9 mio. | 30 mio. | 15.3 mio. | 23 | |
| 2013 | 84.8 mio. | 232 t. | 28.5 mio. | 6.4 mio. | 21 |
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 26 companies in Fremstilling af farmaceutiske råvarer
Comparison is based on industry median values
3 properties
Upgrade to Pro to see addresses, building data and ownership details
Property report (PDF)
The entire property portfolio in one report: areas, usage, energy labels, flood exposure, planning zone and local plans.
See an example report (PDF)Screen owners and management against the Danish FSA's official PEP lists
DANIPHARM A/S has published its annual report for 2025. Gross profit came to DKK 37,586,751, and the net result was DKK 13,717,304.
DANIPHARM A/S has published its annual report for 2024. Gross profit came to DKK 34,065,329, and the net result was DKK 5,113,647.
DANIPHARM A/S has published its annual report for 2023. Gross profit came to DKK 35,151,544, and the net result was DKK 5,390,779.
DANIPHARM A/S has published its annual report for 2022. Gross profit came to DKK 34,935,080, and the net result was DKK 8,190,711.
DANIPHARM A/S has published its annual report for 2021. Gross profit came to DKK 29,394,577, and the net result was DKK 2,944,039.
DANIPHARM A/S has published its annual report for 2020. Revenue came to DKK 91,596,524, and the net result was DKK 5,767,443.
As of February 13, 2020, Svend Blankholm has left the board of directors of DANIPHARM A/S.
DANIPHARM A/S has published its annual report for 2019. Gross profit came to DKK 42,946,302, and the net result was DKK 16,324,503.
DANIPHARM A/S has published its annual report for 2018. Gross profit came to DKK 35,699,249, and the net result was DKK 10,231,404.
DANIPHARM A/S has published its annual report for 2017. Revenue came to DKK 93,581,442, and the net result was DKK 11,319,150.
DANIPHARM A/S has published its annual report for 2016. Revenue came to DKK 85,172,061, and the net result was DKK 15,240,178.
DANIPHARM A/S has published its annual report for 2015. Revenue came to DKK 85,065,452, and the net result was DKK 11,265,725.
DANIPHARM A/S has published its annual report for 2014. Revenue came to DKK 90,097,985, and the net result was DKK 8,871,761.
DANIPHARM A/S has published its annual report for 2013. Revenue came to DKK 84,814,413, and the net result was DKK 232,276.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of DANIPHARM A/S.
As of July 1, 2011, A/S PSE NR. 4820 has stepped down as auditor of DANIPHARM A/S.
As of June 30, 2009, H&P Rørvig Holding A/S is registered as an owner of DANIPHARM A/S with an ownership share of 100%.
As of September 8, 2006, Niels Otto Thiesen has left the board of directors of DANIPHARM A/S.
As of May 31, 2006, Niels Ulrik Heine has joined the board of directors of DANIPHARM A/S.
As of May 31, 2006, Peter Rørvig has joined the board of directors of DANIPHARM A/S.
As of May 31, 2006, Peter Rørvig is registered as director of DANIPHARM A/S.
As of May 31, 2006, Niels Otto Thiesen has stepped down as director of DANIPHARM A/S.
As of November 30, 2005, Helle Rørvig has joined the board of directors of DANIPHARM A/S.
As of June 30, 2005, A/S PSE NR. 4820 has been appointed auditor of DANIPHARM A/S.
As of June 30, 2005, Pricewaterhouse Coopers has stepped down as auditor of DANIPHARM A/S.
As of November 23, 2004, Svend Blankholm has joined the board of directors of DANIPHARM A/S.
As of February 18, 1998, Erik Vilhelm Balslev has left the board of directors of DANIPHARM A/S.
As of November 11, 1996, Erik Vilhelm Balslev has joined the board of directors of DANIPHARM A/S.
As of November 11, 1996, Niels Otto Thiesen has joined the board of directors of DANIPHARM A/S.
As of November 11, 1996, Erik Vilhelm Balslev is registered as director of DANIPHARM A/S.
As of November 11, 1996, Peter Rørvig is registered as director of DANIPHARM A/S.
As of November 11, 1996, Erik Vilhelm Balslev has stepped down as director of DANIPHARM A/S.
As of November 11, 1996, Peter Rørvig has stepped down as director of DANIPHARM A/S.
As of January 18, 1994, Pricewaterhouse Coopers has been appointed auditor of DANIPHARM A/S.
As of January 18, 1994, Svend Blankholm has stepped down as auditor of DANIPHARM A/S.
As of December 22, 1988, Erik Tronborg Andersen has stepped down as auditor of DANIPHARM A/S.
As of December 22, 1988, Per Emil Hasselbalch Stakemann has stepped down as director of DANIPHARM A/S.
As of August 1, 1988, Erik Tronborg Andersen has been appointed auditor of DANIPHARM A/S.
As of August 1, 1988, Svend Blankholm has been appointed auditor of DANIPHARM A/S.
As of August 1, 1988, Per Emil Hasselbalch Stakemann is registered as director of DANIPHARM A/S.
As of August 1, 1988, Niels Otto Thiesen is registered as director of DANIPHARM A/S.
DANIPHARM A/S was founded on August 1, 1988.
Companies in the same industry and area
CVR 15248912
CVR 62550511
CVR 44654482
CVR 61094628
companydata.dk